Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)
China flag China · Delayed Price · Currency is CNY
40.33
-1.48 (-3.54%)
Nov 17, 2026, 3:04 PM CST

SHE:300049 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,6271,5871,3421,1471,001891.56
Other Revenue
8.358.357.496.97.376.93
1,6361,5951,3491,1541,009898.48
Revenue Growth
11.26%18.26%16.93%14.37%12.27%11.26%
Cost of Revenue
405.7400.35350.73291.39267.67239.14
Gross Profit
1,2301,195998.28862.34741.09659.34
Selling, General & Admin
672.76675.19584.24527.56474.49405.7
Research & Development
126.9111.299.4982.4770.8264.79
Other Operating Expenses
16.5310.997.8810.4310.7912.5
Operating Expenses
807.21795.48711.39622562.68491.94
Operating Income
422.88399.56286.89240.34178.41167.4
Interest Expense
-4.29-3.22-2.77-0.9-1.58-2.33
Interest & Investment Income
21.7419.2916.0712.389.7310.54
Currency Exchange Gain (Loss)
-32.29-32.2910.37-2.317.9316.48
Other Non Operating Income (Expenses)
35.2-0.48-2.034.08-1.28-0.26
EBT Excluding Unusual Items
443.23382.85308.53253.59193.21191.83
Impairment of Goodwill
-25.59-25.59-7.7---
Gain (Loss) on Sale of Investments
19.2716.83-23.11---
Gain (Loss) on Sale of Assets
-0.070.38-0.31-0.82-1.86-3.46
Asset Writedown
-6.15-6.95-0-4.71-0-
Legal Settlements
-5.54-5.54----
Other Unusual Items
-8.39-11.42-6.86-12.660.290.77
Pretax Income
416.76350.56270.55235.4191.63189.14
Income Tax Expense
104.0992.1474.6758.2946.2241.1
Earnings From Continuing Operations
312.67258.42195.88177.11145.41148.04
Minority Interest in Earnings
-136.71-104.33-82.59-75.55-47.52-52.57
Net Income
175.96154.09113.29101.5697.8995.47
Net Income to Common
175.96154.09113.29101.5697.8995.47
Net Income Growth
42.86%36.02%11.54%3.75%2.54%54.22%
Shares Outstanding (Basic)
267266263263263260
Shares Outstanding (Diluted)
267266263263263260
Shares Change
3.15%0.84%0.15%-0.01%1.30%1.31%
EPS (Basic)
0.660.580.430.390.370.37
EPS (Diluted)
0.660.580.430.390.370.37
EPS Growth
38.50%34.88%11.37%3.76%1.22%52.22%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
245.64162.512.44115.6698.69142.94
Free Cash Flow Per Share
0.920.610.010.440.380.55
Dividend Per Share
0.0150.015--0.200-
Dividend Growth
------
Gross Margin
75.20%74.91%74.00%74.74%73.47%73.38%
Operating Margin
25.85%25.05%21.27%20.83%17.69%18.63%
Profit Margin
10.76%9.66%8.40%8.80%9.70%10.63%
Free Cash Flow Margin
15.02%10.19%0.18%10.03%9.78%15.91%
EBITDA
506.6478.34359.08307.52236.39221.12
EBITDA Margin
30.97%29.98%26.62%26.65%23.43%24.61%
D&A For EBITDA
83.7278.7872.1967.1857.9853.71
EBIT
422.88399.56286.89240.34178.41167.4
EBIT Margin
25.85%25.05%21.27%20.83%17.69%18.63%
Effective Tax Rate
24.98%26.28%27.60%24.76%24.12%21.73%
Revenue as Reported
1,6361,5951,3491,1541,009898.48
Advertising Expenses
-3.133.344.769.839.3